Lv3
310 积分 2022-08-15 加入
On Bayesian Methods for Bioequivalence
8天前
已完结
Application of complete N-of-1 trial design in bioequivalence-biosimilar drug development
8天前
已完结
Safety and effectiveness of selpercatinib in patients with RET fusion-positive non-small cell lung cancer in real-world clinical practice: a postmarketing study in Japan
1个月前
已关闭
Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma
1个月前
已完结
Mechanistic Pharmacokinetics and Pharmacodynamics of GalNAc-siRNA: Translational Model Involving Competitive Receptor-Mediated Disposition and RISC-Dependent Gene Silencing Applied to Givosiran
1个月前
已完结
Bioequivalence and Evaluation Parameters Based on the Pharmacodynamics of Miglitol in Healthy Volunteers
1个月前
已完结
Bioequivalence and Evaluation Parameters Based on the Pharmacodynamics of Miglitol in Healthy Volunteers
1个月前
已完结
Acarbose bioequivalence: Exploration of eligible protocol design
1个月前
已完结
皖公网安备34019202002308
